XNCR · Xencor Inc. Common Stock
View on chartInsiders & Stakes
| Xencor Inc | ▲ Buy | Option Exercise | 1,885,533 Shares held | 9/3/2021 | View profile |
| Bassil I. Dahiyat PRESIDENT & CEO | ▼ Sell | Open Market | 546,316 Shares held | 3/6/2026 | View profile |
| John R. Desjarlais SR. VICE PRESIDENT & CSO | ▼ Sell | Open Market | 263,831 Shares held | 3/6/2026 | View profile |
| Kuch John J SR. VICE PRESIDENT & CFO | ▼ Sell | Open Market | 121,070 Shares held | 3/11/2024 | View profile |
| Celia Eckert VP, GENERAL COUNSEL | ▼ Sell | Open Market | 76,918 Shares held | 3/6/2026 | View profile |
| Bart Jan Cornelissen SR. VICE PRESIDENT & CFO | ▼ Sell | Open Market | 75,898 Shares held | 4/10/2026 | View profile |
| Yang Allen SR. VICE PRESIDENT & CMO | ▼ Sell | Open Market | 73,364 Shares held | 3/9/2023 | View profile |
| Nancy Valente EVP, Chief Development Officer | ▼ Sell | Open Market | 49,169 Shares held | 5/2/2025 | View profile |
| Barbara Klencke Director | ▲ Buy | Grant | 29,974 Shares held | 6/16/2026 | View profile |
| Alan Bruce Montgomery Director | ▲ Buy | Grant | 25,849 Shares held | 6/16/2026 | View profile |
| Kurt A. Gustafson Director | ▲ Buy | Grant | 25,011 Shares held | 6/16/2026 | View profile |
| Richard J. Ranieri Director | ▲ Buy | Grant | 24,011 Shares held | 6/16/2026 | View profile |
| Todd E. Simpson Director | ▲ Buy | Grant | 23,988 Shares held | 6/16/2026 | View profile |
| Kevin Charles Gorman Director | ▲ Buy | Grant | 21,680 Shares held | 6/16/2026 | View profile |
| Ellen Feigal Director | ▼ Sell | Open Market | 12,340 Shares held | 6/18/2026 | View profile |
| Raymond Joseph Deshaies Director | ▲ Buy | Grant | 10,302 Shares held | 6/16/2026 | View profile |
| ROSA-BJORKESON DAGMAR Director | ▼ Sell | Open Market | 8,490 Shares held | 9/27/2024 | View profile |
Transaction History
| Ellen Feigal | ▼ Sell | Open Market | 6,843 | $89K | 6/18/2026 |
| Kevin Charles Gorman | ▲ Buy | Grant | 10,302 | $0 | 6/16/2026 |
| Kurt A. Gustafson | ▲ Buy | Grant | 10,302 | $0 | 6/16/2026 |
| Barbara Klencke | ▲ Buy | Grant | 10,302 | $0 | 6/16/2026 |
| Alan Bruce Montgomery | ▲ Buy | Grant | 10,302 | $0 | 6/16/2026 |
| Richard J. Ranieri | ▲ Buy | Grant | 10,302 | $0 | 6/16/2026 |
| Todd E. Simpson | ▲ Buy | Grant | 10,302 | $0 | 6/16/2026 |
| Raymond Joseph Deshaies | ▲ Buy | Grant | 10,302 | $0 | 6/16/2026 |
| Ellen Feigal | ▲ Buy | Grant | 10,302 | $0 | 6/16/2026 |
| Kevin Charles Gorman | ▼ Sell | Open Market | 7,527 | $93K | 6/15/2026 |
| Kurt A. Gustafson | ▼ Sell | Open Market | 5,474 | $67K | 6/15/2026 |
| Richard J. Ranieri | ▼ Sell | Open Market | 5,474 | $67K | 6/15/2026 |
| Alan Bruce Montgomery | ▼ Sell | Open Market | 5,064 | $62K | 6/15/2026 |
| Bart Jan Cornelissen | ▼ Sell | Open Market | 3,499 | $43K | 4/10/2026 |
| John R. Desjarlais | ▼ Sell | Open Market | 2,502 | $28K | 3/6/2026 |
| Celia Eckert | ▼ Sell | Open Market | 1,767 | $19K | 3/6/2026 |
| Bassil I. Dahiyat | ▼ Sell | Open Market | 6,606 | $73K | 3/6/2026 |
| John R. Desjarlais | ▼ Sell | Open Market | 4,118 | $46K | 3/5/2026 |
| Celia Eckert | ▼ Sell | Open Market | 3,244 | $36K | 3/5/2026 |
| Bart Jan Cornelissen | ▼ Sell | Open Market | 2,517 | $28K | 3/5/2026 |
| Bassil I. Dahiyat | ▼ Sell | Open Market | 14,870 | $167K | 3/5/2026 |
| John R. Desjarlais | ▼ Sell | Open Market | 2,663 | $32K | 3/3/2026 |
| Celia Eckert | ▼ Sell | Open Market | 1,492 | $18K | 3/3/2026 |
| Bassil I. Dahiyat | ▼ Sell | Open Market | 6,758 | $80K | 3/3/2026 |
| John R. Desjarlais | ▲ Buy | Grant | 24,907 | $0 | 3/2/2026 |
| Bart Jan Cornelissen | ▲ Buy | Grant | 19,458 | $0 | 3/2/2026 |
| Celia Eckert | ▲ Buy | Grant | 18,680 | $0 | 3/2/2026 |
| Bassil I. Dahiyat | ▲ Buy | Grant | 97,291 | $0 | 3/2/2026 |
| John R. Desjarlais | ▲ Buy | Option Exercise | 5,322 | $67K | 1/23/2026 |
| John R. Desjarlais | ▲ Buy | Option Exercise | 6,311 | $79K | 12/22/2025 |
| Bassil I. Dahiyat | ▲ Buy | Option Exercise | 10,624 | $133K | 12/22/2025 |
| John R. Desjarlais | ▲ Buy | Option Exercise | 73,367 | $918K | 12/19/2025 |
| John R. Desjarlais | ▼ Sell | Open Market | 73,367 | $1.2M | 12/19/2025 |
| Bassil I. Dahiyat | ▲ Buy | Option Exercise | 114,377 | $1.4M | 12/19/2025 |
| Bassil I. Dahiyat | ▼ Sell | Open Market | 114,377 | $1.8M | 12/19/2025 |
| Alan Bruce Montgomery | ▼ Sell | Open Market | 2,215 | $20K | 6/16/2025 |
| Kurt A. Gustafson | ▼ Sell | Open Market | 2,993 | $28K | 6/16/2025 |
| Kevin Charles Gorman | ▼ Sell | Open Market | 3,173 | $29K | 6/16/2025 |
| Ellen Feigal | ▼ Sell | Open Market | 2,993 | $28K | 6/16/2025 |
| Richard J. Ranieri | ▼ Sell | Open Market | 2,993 | $28K | 6/16/2025 |
| Alan Bruce Montgomery | ▲ Buy | Grant | 13,686 | $0 | 6/12/2025 |
| Barbara Klencke | ▲ Buy | Grant | 13,686 | $0 | 6/12/2025 |
| Kurt A. Gustafson | ▲ Buy | Grant | 13,686 | $0 | 6/12/2025 |
| Kevin Charles Gorman | ▲ Buy | Grant | 13,686 | $0 | 6/12/2025 |
| Ellen Feigal | ▲ Buy | Grant | 13,686 | $0 | 6/12/2025 |
| Todd E. Simpson | ▲ Buy | Grant | 13,686 | $0 | 6/12/2025 |
| Richard J. Ranieri | ▲ Buy | Grant | 13,686 | $0 | 6/12/2025 |
| Nancy Valente | ▼ Sell | Open Market | 4,616 | $51K | 5/2/2025 |
| Bart Jan Cornelissen | ▼ Sell | Open Market | 3,750 | $30K | 4/10/2025 |
| Nancy Valente | ▼ Sell | Open Market | 2,565 | $35K | 3/10/2025 |
| Celia Eckert | ▼ Sell | Open Market | 5,740 | $78K | 3/10/2025 |
| John R. Desjarlais | ▼ Sell | Open Market | 9,697 | $132K | 3/10/2025 |
| Bassil I. Dahiyat | ▼ Sell | Open Market | 19,716 | $268K | 3/10/2025 |
| John R. Desjarlais | ▲ Buy | Grant | 29,851 | $0 | 3/4/2025 |
| Celia Eckert | ▲ Buy | Grant | 21,949 | $0 | 3/4/2025 |
| Bassil I. Dahiyat | ▲ Buy | Grant | 109,745 | $0 | 3/4/2025 |
| Bart Jan Cornelissen | ▲ Buy | Grant | 21,949 | $0 | 3/4/2025 |
| Bassil I. Dahiyat | ▲ Buy | Option Exercise | 8,808 | $138K | 2/3/2025 |
| John R. Desjarlais | ▲ Buy | Option Exercise | 3,542 | $56K | 2/3/2025 |
| Alan Bruce Montgomery | ▲ Buy | Option Exercise | 991 | $15K | 12/4/2024 |
| Alan Bruce Montgomery | ▼ Sell | Open Market | 1,421 | $38K | 12/4/2024 |
| Alan Bruce Montgomery | ▲ Buy | Option Exercise | 430 | $9K | 12/4/2024 |
| Alan Bruce Montgomery | ▼ Sell | Open Market | 13,301 | $360K | 12/2/2024 |
| Alan Bruce Montgomery | ▲ Buy | Option Exercise | 8,293 | $127K | 12/2/2024 |
| Alan Bruce Montgomery | ▲ Buy | Option Exercise | 5,008 | $100K | 12/2/2024 |
| Bassil I. Dahiyat | ▲ Buy | Option Exercise | 13,548 | $213K | 11/22/2024 |
| Bassil I. Dahiyat | ▲ Buy | Option Exercise | 49,278 | $773K | 11/21/2024 |
| Bassil I. Dahiyat | ▼ Sell | Open Market | 49,278 | $1.2M | 11/21/2024 |
| Bassil I. Dahiyat | ▲ Buy | Option Exercise | 3,366 | $53K | 11/13/2024 |
| Bassil I. Dahiyat | ▼ Sell | Open Market | 3,366 | $81K | 11/13/2024 |
| John R. Desjarlais | ▲ Buy | Option Exercise | 12,774 | $200K | 11/12/2024 |
| John R. Desjarlais | ▼ Sell | Open Market | 68,684 | $1.6M | 11/11/2024 |
| John R. Desjarlais | ▲ Buy | Option Exercise | 68,684 | $1.1M | 11/11/2024 |
| ROSA-BJORKESON DAGMAR | ▼ Sell | Open Market | 2,503 | $52K | 9/27/2024 |
| Richard J. Ranieri | ▼ Sell | Open Market | 2,503 | $52K | 9/27/2024 |
| Kevin Charles Gorman | ▼ Sell | Open Market | 2,654 | $55K | 9/27/2024 |
| Alan Bruce Montgomery | ▼ Sell | Open Market | 1,853 | $38K | 9/27/2024 |
| Ellen Feigal | ▼ Sell | Open Market | 2,503 | $52K | 9/27/2024 |
| Kurt A. Gustafson | ▼ Sell | Open Market | 2,503 | $52K | 9/27/2024 |
| John R. Desjarlais | ▲ Buy | Option Exercise | 7,785 | $84K | 7/10/2024 |
| John R. Desjarlais | ▼ Sell | Open Market | 36,329 | $666K | 7/9/2024 |
| John R. Desjarlais | ▲ Buy | Option Exercise | 42,215 | $453K | 7/9/2024 |
| Alan Bruce Montgomery | ▲ Buy | Grant | 5,986 | $0 | 6/13/2024 |
| Kurt A. Gustafson | ▲ Buy | Grant | 5,986 | $0 | 6/13/2024 |
| Ellen Feigal | ▲ Buy | Grant | 5,986 | $0 | 6/13/2024 |
| ROSA-BJORKESON DAGMAR | ▲ Buy | Grant | 5,986 | $0 | 6/13/2024 |
| Kevin Charles Gorman | ▲ Buy | Grant | 5,986 | $0 | 6/13/2024 |
| Richard J. Ranieri | ▲ Buy | Grant | 5,986 | $0 | 6/13/2024 |
| Barbara Klencke | ▲ Buy | Grant | 5,986 | $0 | 6/13/2024 |
| Nancy Valente | ▼ Sell | Open Market | 4,745 | $112K | 5/2/2024 |
| Bart Jan Cornelissen | ▲ Buy | Grant | 42,265 | $0 | 4/9/2024 |
| Kuch John J | ▼ Sell | Open Market | 849 | $20K | 3/11/2024 |
| Celia Eckert | ▼ Sell | Open Market | 850 | $20K | 3/11/2024 |
| John R. Desjarlais | ▼ Sell | Open Market | 1,280 | $30K | 3/11/2024 |
| Bassil I. Dahiyat | ▼ Sell | Open Market | 2,741 | $64K | 3/11/2024 |
| Kurt A. Gustafson | ▲ Buy | Option Exercise | 15,000 | $161K | 3/6/2024 |
| Kurt A. Gustafson | ▼ Sell | Open Market | 14,000 | $324K | 3/6/2024 |
| Bassil I. Dahiyat | ▼ Sell | Open Market | 12,528 | $294K | 3/5/2024 |
| Bassil I. Dahiyat | ▲ Buy | Grant | 54,538 | $0 | 3/5/2024 |
| Celia Eckert | ▲ Buy | Grant | 13,089 | $0 | 3/5/2024 |
| John R. Desjarlais | ▼ Sell | Open Market | 6,629 | $155K | 3/5/2024 |
| John R. Desjarlais | ▲ Buy | Grant | 20,724 | $0 | 3/5/2024 |
| Celia Eckert | ▼ Sell | Open Market | 3,892 | $91K | 3/5/2024 |
| Kuch John J | ▼ Sell | Open Market | 4,474 | $105K | 3/5/2024 |
| Nancy Valente | ▲ Buy | Grant | 19,634 | $0 | 3/5/2024 |
| John R. Desjarlais | ▲ Buy | Option Exercise | 11,943 | $132K | 2/14/2024 |
| Kevin Charles Gorman | ▲ Buy | Open Market | 53 | $1K | 2/13/2024 |
| John R. Desjarlais | ▲ Buy | Option Exercise | 68,057 | $752K | 2/13/2024 |
| John R. Desjarlais | ▼ Sell | Open Market | 54,108 | $1.0M | 2/13/2024 |
| Bassil I. Dahiyat | ▲ Buy | Option Exercise | 65,001 | $718K | 12/29/2023 |
| Bassil I. Dahiyat | ▼ Sell | Open Market | 45,000 | $942K | 12/29/2023 |
| Bassil I. Dahiyat | ▼ Sell | Open Market | 33,497 | $877K | 6/21/2023 |
| Bassil I. Dahiyat | ▲ Buy | Option Exercise | 76,012 | $323K | 6/21/2023 |
| Alan Bruce Montgomery | ▲ Buy | Grant | 5,007 | $0 | 6/20/2023 |
| ROSA-BJORKESON DAGMAR | ▲ Buy | Grant | 5,007 | $0 | 6/20/2023 |
| Ellen Feigal | ▲ Buy | Grant | 5,007 | $0 | 6/20/2023 |
| Richard J. Ranieri | ▲ Buy | Grant | 5,007 | $0 | 6/20/2023 |
| Kevin Charles Gorman | ▲ Buy | Grant | 5,007 | $0 | 6/20/2023 |
| Kurt A. Gustafson | ▲ Buy | Grant | 5,007 | $0 | 6/20/2023 |
| Nancy Valente | ▲ Buy | Grant | 39,296 | $0 | 5/1/2023 |
| Yang Allen | ▼ Sell | Open Market | 1,094 | $33K | 3/9/2023 |
| Celia Eckert | ▼ Sell | Open Market | 711 | $21K | 3/9/2023 |
| Kuch John J | ▼ Sell | Open Market | 711 | $21K | 3/9/2023 |
| Bassil I. Dahiyat | ▼ Sell | Open Market | 2,602 | $78K | 3/9/2023 |
| John R. Desjarlais | ▼ Sell | Open Market | 1,230 | $37K | 3/9/2023 |
| Yang Allen | ▼ Sell | Open Market | 4,069 | $128K | 3/6/2023 |
| Bassil I. Dahiyat | ▼ Sell | Open Market | 5,831 | $183K | 3/6/2023 |
| Celia Eckert | ▼ Sell | Open Market | 2,462 | $77K | 3/6/2023 |
| John R. Desjarlais | ▼ Sell | Open Market | 4,195 | $132K | 3/6/2023 |
| Kuch John J | ▼ Sell | Open Market | 2,774 | $87K | 3/6/2023 |
| Kuch John J | ▼ Sell | Open Market | 919 | $29K | 3/3/2023 |
| Celia Eckert | ▼ Sell | Open Market | 427 | $13K | 3/3/2023 |
| John R. Desjarlais | ▼ Sell | Open Market | 1,232 | $39K | 3/3/2023 |
| Bassil I. Dahiyat | ▼ Sell | Open Market | 2,851 | $90K | 3/3/2023 |
| Celia Eckert | ▲ Buy | Grant | 10,504 | $0 | 3/2/2023 |
| Kuch John J | ▲ Buy | Grant | 12,005 | $0 | 3/2/2023 |
| Bassil I. Dahiyat | ▲ Buy | Grant | 52,521 | $0 | 3/2/2023 |
| John R. Desjarlais | ▲ Buy | Grant | 18,758 | $0 | 3/2/2023 |
| Yang Allen | ▲ Buy | Grant | 15,006 | $0 | 3/2/2023 |
| Yang Allen | ▼ Sell | Open Market | 3,737 | $101K | 12/19/2022 |
| John R. Desjarlais | ▼ Sell | Open Market | 1,172 | $34K | 3/9/2022 |
| Bassil I. Dahiyat | ▼ Sell | Open Market | 2,494 | $72K | 3/9/2022 |
| Yang Allen | ▼ Sell | Open Market | 1,200 | $35K | 3/9/2022 |
| Celia Eckert | ▼ Sell | Open Market | 789 | $23K | 3/9/2022 |
| Kuch John J | ▼ Sell | Open Market | 690 | $20K | 3/9/2022 |
| Kuch John J | ▼ Sell | Open Market | 971 | $29K | 3/3/2022 |
| Celia Eckert | ▼ Sell | Open Market | 451 | $13K | 3/3/2022 |
| John R. Desjarlais | ▼ Sell | Open Market | 1,240 | $37K | 3/3/2022 |
| Bassil I. Dahiyat | ▼ Sell | Open Market | 2,929 | $88K | 3/3/2022 |
| Bassil I. Dahiyat | ▲ Buy | Grant | 49,761 | $0 | 3/3/2022 |
| Kuch John J | ▲ Buy | Grant | 23,222 | $0 | 3/3/2022 |
| John R. Desjarlais | ▲ Buy | Grant | 35,828 | $0 | 3/3/2022 |
| Celia Eckert | ▲ Buy | Grant | 19,904 | $0 | 3/3/2022 |
| Yang Allen | ▲ Buy | Grant | 33,174 | $0 | 3/3/2022 |
| Yang Allen | ▼ Sell | Open Market | 3,664 | $134K | 12/17/2021 |
| Xencor Inc | ▲ Buy | Option Exercise | 108,000 | $842K | 9/3/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
XNCR: Improved Funding for Obexelimab
Xencor announced that it has secured better funding for its experimental antibody Obexelimab, which could support further development of the therapy. The news comes as the stock is near its 18‑touch support level of $12 and still below the 52‑week low of $10.38. Analysts maintain a target of $31.42, indicating that the funding may help the company move toward that goal.
XNCR: Improved Funding for Obexelimab. Xencor announced that it has secured better funding for its experimental antibody Obexelimab, which could support further development of the therapy. The news comes as the stock is near its 18‑touch support level of $12 and still below the 52‑week low of $10.38. Analysts maintain a target of $31.42, indicating that the funding may help the company move toward that goal.